NovoSeven RT

NovoSeven RT Indications/Uses

factor viia, recombinant


Novo Nordisk
Full Prescribing Info
NovoSeven RT is indicated for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups: in patients with congenital haemophilia with inhibitors to coagulation factors VIII or IX >5 Bethesda Units (BU);
in patients with congenital haemophilia who are expected to have a high anamnestic response to factor VIII or factor IX administration;
in patients with acquired haemophilia;
in patients with congenital FVII deficiency;
in patients with Glanzmann's thrombasthenia with antibodies to GP IIb-IIIa and/or HLA, and with past or present refractoriness to platelets transfusions.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in